Lung Cancer Screening: Advantages, controversies, and applications

Cancer Control

Volumn 21, Issue 1, 2014, Pages 9-14

  Nanavaty, Prema ^a   Alvarez, Michael S ^a   Michael Alberts, W ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; FALSE POSITIVE RESULT; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; OUTCOME ASSESSMENT; RADIATION DOSE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THORAX RADIOGRAPHY;

COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84890949208     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481402100102     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts & Figures 2013. Atlanta, GA: American Cancer Society; 2013.
2. American Lung Association. Providing guidance on lung cancer screening to patients and physicians. http://www.lung.org/lung-disease/ lung-cancer/lung-cancer-screening-guidelines/lung-cancer-screening.pdf. Accessed August 22, 2013.
3. US Office of the Surgeon General. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Bethesda, MD: US National Library of Medicine; 1964. Pub. No. 1108.
4. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418-2429.
5. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
6. Collins LG, Haines C, Perkel R, et al. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75(1):56-63.
7. MacRedmond R, McVey G, Lee M, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax. 2006;61(1): 54-56.
8. Wiener RS, Schwartz LM, Woloshin S, et al. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med. 2011;155(3):137-144.
9. Brunelli A, Kim AW, Berger KI, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 suppl):e166S-e190S.
10. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011;6(11):1841-1848.
11. Wendling P. New questions on lung cancer screening. www.internalmedicinenews. com/index.php?id=514&tx_ttnews%5Btt_news%5D=93814& cHash=d03601233e1e24e8ca693713b602d766. Accessed August 22, 2013.
12. Gazdar AF, Thun MJ. Lung cancer, smoke exposure, and sex. J Clin Oncol. 2007;25(5):469-471.
13. Lark FJ, Kruger RL, Cagnon CH, et al. Estimated radiation associated with low-dose CT of average-size participants on the National Lung Screening Trial. AJR Am J Roentgenol. 2011;197(5):1165-1169.
14. Radiological Society of North America. Radiology info for patients. www.radiologyinfo.org. Accessed August 22, 2013.
15. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in Mayo Lung project: impact of extended follow-up. J Natl Cancer Inst. 2000;92(16):1308-1316.
16. Marcus PM, Bergstralh EJ, Zweig MH, et al. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnsosis. J Natl Cancer Inst. 2006;98(11):748-756.
17. Oken MM, Marcus PM, Hu P, et al. Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst. 2005;97(24):1832-1839.
18. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67(4):296-301.
19. Infante M, Cavuto S, Lutman FR, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180(5):445-453.
20. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer. 2007;120(4):868-874.
21. Lopes Pegna A, Picozzi G, Mascalchi M, et al. Design, recruitment and baseline results of the ITALUNG lung cancer screening with low dose CT. Lung Cancer. 2009;64(1):34-40.
22. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361(23):2221-2229.
23. Paci E. The ITALUNG study and the state of art of randomized screening trials in Europe. Cancer Prevent Res. 2011;4(10 suppl 1):SS03-03.
24. Gu Y, Kumar V, Hall LO, et al. Automated delineation of lung tumors from CT images using a single click ensemble segmentation approach. Pattern Recognit. 2013;46(3):692-702.